[ FDA DRUG SHORTAGES TRACKER ]

A drug shortage is a quality failure with a body count.

Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.

1,000
Active shortages tracked
852
Current
147
To be discontinued
212
Flagged unavailable
21% flagged unavailable · latest update 2026-07-30 · source: openFDA drug/shortages
NEW SHORTAGES POSTED · MONTHLY

By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.

ACTIVE SHORTAGES BY THERAPEUTIC CATEGORY · TOP 10
WHY THIS SITS UNDER QUALITY, NOT LOGISTICS

The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.

The economics of quality →FDA QMM framework →
Reset
1,178 matching shortages
DrugCompanyTherapeutic areaAvailabilityStatusPosted
Bupivacaine Hydrochloride InjectionInjectionKindos Pharmaceuticals Co. Ltd.Anesthesia—To Be Discontinued2026-05-05
Bupivacaine Hydrochloride InjectionInjectionKindos Pharmaceuticals Co. Ltd.AnesthesiaLimitedCurrent2018-02-20
Bupivacaine Hydrochloride InjectionInjectionKindos Pharmaceuticals Co. Ltd.Anesthesia—To Be Discontinued2026-05-05
Bupivacaine Hydrochloride InjectionInjectionKindos Pharmaceuticals Co. Ltd.Anesthesia—To Be Discontinued2026-05-05
Bupivacaine Hydrochloride InjectionInjectionKindos Pharmaceuticals Co. Ltd.AnesthesiaLimitedCurrent2018-02-20
Desmopressin Acetate SpraySprayFerringHematologyUnavailableCurrent2021-03-12
Desmopressin Acetate SpraySprayFerringHematologyUnavailableCurrent2021-03-12
Desmopressin Acetate SpraySprayFerringHematologyUnavailableCurrent2021-03-12
Lamotrigine Tablet, Extended ReleaseTabletPar Health, Inc.Neurology—To Be Discontinued2026-04-29
Lamotrigine Tablet, Extended ReleaseTabletPar Health, Inc.Neurology—To Be Discontinued2026-04-29
Lamotrigine Tablet, Extended ReleaseTabletPar Health, Inc.Neurology—To Be Discontinued2026-04-29
Lamotrigine Tablet, Extended ReleaseTabletPar Health, Inc.Neurology—To Be Discontinued2026-04-29
Lamotrigine Tablet, Extended ReleaseTabletPar Health, Inc.Neurology—To Be Discontinued2026-04-29
Lamotrigine Tablet, Extended ReleaseTabletPar Health, Inc.Neurology—To Be Discontinued2026-04-29
Furosemide InjectionInjectionGland Pharma LimitedCardiovascular—To Be Discontinued2026-04-28
Crinecerfont CapsuleCapsuleNeurocrine Biosciences, Inc.Endocrinology/Metabolism—To Be Discontinued2026-04-28
Etravirine TabletTabletJanssen Research and DevelopmentAntiviral—To Be Discontinued2026-04-28
Etravirine TabletTabletJanssen Research and DevelopmentAntiviral—To Be Discontinued2026-04-28
Furosemide InjectionInjectionGland Pharma LimitedCardiovascular—To Be Discontinued2026-04-28
Furosemide InjectionInjectionGland Pharma LimitedCardiovascular—To Be Discontinued2026-04-28
Furosemide InjectionInjectionMeitheal Pharmaceuticals, Inc.CardiovascularAvailableCurrent2020-04-07
Furosemide InjectionInjectionMeitheal Pharmaceuticals, Inc.CardiovascularAvailableCurrent2020-04-07
Furosemide InjectionInjectionMeitheal Pharmaceuticals, Inc.CardiovascularAvailableCurrent2020-04-07
Palbociclib CapsuleCapsulePfizer Inc.Oncology—To Be Discontinued2026-04-22
Palbociclib CapsuleCapsulePfizer Inc.Oncology—To Be Discontinued2026-04-22
Page 38 of 48
← PrevNext →

Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).